company
Medtronic Neuromodulation
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_recall · device_recall2026-06-03Medtronic Neuromodulation — Class II recall: Medtronic 1x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64001; Stimul…
- fda_recall · device_recall2026-06-03Medtronic Neuromodulation — Class II recall: Medtronic 2x4 Pocket Adaptor Kit for Deep Brain Stimulation, Model 64002; Stimul…
- fda_recall · device_recall2026-05-20Medtronic Neuromodulation — Class II recall: Medtronic SynchroMed Flex Infusion Mode - A810 Clinician Programmer Software App…
Frequently asked questions
- How many FDA warning letters has Medtronic Neuromodulation received?
- Argus HQ has not recorded an FDA warning letter for Medtronic Neuromodulation in our current dataset.
- What FDA recalls has Medtronic Neuromodulation issued?
- Argus HQ has recorded 3 FDA recalls tied to Medtronic Neuromodulation.
- Is Medtronic Neuromodulation FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 3 recalls, and 0 approval records for Medtronic Neuromodulation. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.

